Validations: Stability Program Scale-Up & Network Governance

Bridging Protocols During Transfers and Launches

Bridging Protocols During Transfers and Launches Bridging Protocols During Transfers and Launches Introduction to Stability Program Scale-Up and Global Protocol Harmonization The pharmaceutical industry faces the perpetual challenge of ensuring product stability while adhering to rigorous regulatory guidelines set forth by governing bodies such as the FDA, EMA, and MHRA. Stability testing is critical to understand how products behave over…

Continue Reading Bridging Protocols During Transfers and Launches

Protocol Change Control: Verification vs Re-Validation

Protocol Change Control: Verification vs Re-Validation The pharmaceutical industry faces constant regulatory scrutiny regarding product stability, necessitating robust protocols to ensure compliance with international standards such as those set by the US FDA, EMA, and MHRA. This comprehensive guide delves into the intricacies of protocol change control, focusing on the distinctions between verification and re-validation within the context of stability…

Continue Reading Protocol Change Control: Verification vs Re-Validation

Split-File Governance: Who Owns What in the Network

Split-File Governance: Who Owns What in the Network Understanding Split-File Governance in Pharmaceutical Networks In the pharmaceutical industry, effective governance ensures that stability programs are streamlined, compliant, and capable of meeting regulatory expectations. Split-file governance, a concept increasingly utilized in large-scale stability programs, helps organizations define ownership and responsibilities within their complex networks. This guide is designed to help pharmaceutical…

Continue Reading Split-File Governance: Who Owns What in the Network

Labeling/Packaging Variants: Impact on Stability Design

Labeling/Packaging Variants: Impact on Stability Design Introduction to Stability Program Scale-Up The stability of pharmaceutical products is a critical consideration in ensuring their safety and efficacy throughout their shelf life. A stability program, therefore, serves as a framework that encompasses a series of protocols aimed at evaluating and ensuring the integrity of pharmaceutical products. This guide will focus on the…

Continue Reading Labeling/Packaging Variants: Impact on Stability Design

Photostability Harmonization: ICH Q1B Across Sites

Photostability Harmonization: ICH Q1B Across Sites The alignment of pharmaceutical stability protocols across disparate sites is a pivotal aspect for ensuring compliance with international regulatory standards. Photostability, as defined by ICH Q1B, plays a crucial role in affirming the stability of pharmaceuticals under light exposure conditions. This guide elucidates a step-by-step tutorial approach to harmonizing photostability protocols across sites while…

Continue Reading Photostability Harmonization: ICH Q1B Across Sites

Micro/Endotoxin in Stability: When Required, When Not

Micro/Endotoxin in Stability: When Required, When Not Understanding Microbial Limits in Stability Studies The integrity of pharmaceutical products is paramount in ensuring patient safety and compliance with regulatory standards. A critical aspect of maintaining this integrity during stability studies involves assessing microbial contamination, particularly endotoxins and microbial levels. These assessments are influenced by several factors, primarily protocol design, stability program…

Continue Reading Micro/Endotoxin in Stability: When Required, When Not

Global Stability Protocol Template: Core vs Local Appendices

Global Stability Protocol Template: Core vs Local Appendices Global Stability Protocol Template: Core vs Local Appendices In the pharmaceutical industry, the development of a comprehensive stability protocol is essential to ensure the long-term integrity and quality of drug products. The core of this stability protocol is the global protocol harmonization effort that aims to standardize processes across regions while accommodating…

Continue Reading Global Stability Protocol Template: Core vs Local Appendices

Harmonizing Long-Term/Intermediate/Accelerated Conditions

Harmonizing Long-Term/Intermediate/Accelerated Conditions Stability studies are an essential part of pharmaceutical development, ensuring that products maintain their quality, safety, and efficacy over time. This article aims to provide pharmaceutical professionals with a comprehensive guide on harmonizing stability protocols, focusing on global protocol harmonization, chamber qualification, excursion governance, and OOT/OOS analytics. By adhering to the principles laid out by regulatory bodies…

Continue Reading Harmonizing Long-Term/Intermediate/Accelerated Conditions

Variant Management: Country-Specific Pulls and Tests

Variant Management: Country-Specific Pulls and Tests Variant Management: Country-Specific Pulls and Tests Introduction to Variant Management in Stability Programs Variant management within the pharmaceutical industry is increasingly significant, especially as companies expand their stability program scale-up initiatives. Global protocol harmonization is essential for establishing consistency across projects, which can enhance efficiency and compliance with regulatory expectations. This article provides a…

Continue Reading Variant Management: Country-Specific Pulls and Tests

Spec Alignment Across Markets: Guardbands and Justifications

Spec Alignment Across Markets: Guardbands and Justifications Spec Alignment Across Markets: Guardbands and Justifications Introduction to Global Protocol Harmonization In the pharmaceutical industry, particularly in the context of a stability program scale-up, the alignment of specifications across different markets is critical. This involves global protocol harmonization, wherein stability testing protocols need to be standardized to satisfy regulatory requirements in various…

Continue Reading Spec Alignment Across Markets: Guardbands and Justifications